Table 2.
Patient characteristics taken into account when considering to postpone/reschedule cancer treatment during the COVID-19 pandemic
| Urban n (%) |
Sub/rural n (%) |
Chi-square p-value | |
|---|---|---|---|
| Comorbidities | 111 (77.1) | 84 (66.1) | 0.045 |
| Cancer stage | 106 (73.6) | 85 (66.9) | 0.229 |
| Frailty | 102 (70.8) | 86 (67.7) | 0.579 |
| Performance status (patient’s ability to perform certain activities of daily living without help) | 88 (61.1) | 67 (52.8) | 0.165 |
| Age | 78 (54.2) | 55 (43.3) | 0.074 |
| Life expectancy | 69 (47.9) | 40 (31.5) | 0.006 |
| Family member access (family member attendance in clinic visits, hospital stays) | 57 (39.6) | 29 (22.8) | 0.003 |
| Psychosocial status (emotional and social functioning) | 55 (38.2) | 32 (25.2) | 0.022 |
| Transportation | 52 (36.1) | 38 (29.9) | 0.280 |
| Insurance | 10 (6.9) | 4 (3.1) | 0.159 |
| Employment | 5 (3.5) | 2 (1.6) | 0.326 |
| Other | 25 (17.4) | 23 (18.1) | 0.872 |